PATENT CLAIM ANALYSIS

Application Number: 16153301
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "326000"]

Abstract:
Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.

Claim (Index 50):
The method of  claim 40 , wherein a single oral transmucosal administration of the dosage form to the subject results in a bioavailability of greater than 65%.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655316', '15092127', '14517260', '11985162', '12521949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8659641796868643
- 35 USC 102 Novelty (BERT): 0.6417285232104759
- Combined Prediction Score: 0.8435406140392255
- Mean Citation Score: 633.91875
- Max Citation Score: 645.74725
- Similarity Product: 578.1041623275728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test